title: Histone modifications and chromatin organization in prostate cancer.
abstract: Epigenetic mechanisms, including histone modifications, nucleosomal remodeling and chromosomal looping, contribute to the onset and progression of prostate cancer. Recent technical advances significantly increase our understanding of the genome-wide epigenetic regulation of gene expression in prostate cancer. Aberrant genomic distribution and global level of histone modifications, nucleosome repositioning at the gene promoter and enhancer regions, as well as androgen receptor-mediated chromosomal looping may lead to the silencing of tumor suppressor genes and the activation of proto-oncogenes. In addition, androgen receptor-induced chromosomal looping facilitates recurrent gene fusion in prostate cancer. Studies in epigenetic regulation have translational implications in the identification of new biomarkers and the development of new therapies in prostate cancer.
authors.affiliation: Department of Molecular & Cellular Biochemistry & Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
authors.forename: Zhong
authors.initials: Z
authors.lastname: Chen
authors.forename: Liguo
authors.initials: L
authors.lastname: Wang
authors.forename: Qianben
authors.initials: Q
authors.lastname: Wang
authors.forename: Wei
authors.initials: W
authors.lastname: Li
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002843:Chromatin / Q000235:genetics* / Q000502:physiology; D047369:Chromatin Immunoprecipitation / Q000379:methods; D044127:Epigenesis, Genetic / Q000235:genetics / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology*; D020868:Gene Silencing; D016147:Genes, Tumor Suppressor / Q000502:physiology; D059014:High-Throughput Nucleotide Sequencing / Q000379:methods; D006657:Histones / Q000235:genetics*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics*
chemical_list: D015415:Biomarkers; D002843:Chromatin; D006657:Histones